Association of HLA-DRB1, DQA1 and DQB1 alleles and haplotypes with common variable immunodeficiency in Iranian patients

Avicenna Journal of Medical Biotechnology

Volumn 4, Issue 2, 2012, Pages 103-112

  Amanzadeh, Amir ^a   Amirzargar, Ali Akbar ^a,b   Mohseni, Nilufar ^a   Arjang, Zohreh ^a   Aghamohammadi, Asghar ^c   Shokrgozar, Mohammad Ali ^a   Shokri, Fazel ^a,b  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alleles; Haplotypes; HLA antigens; Immunodeficiency

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; IRAN; MALE; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 84862019133     PISSN: 20082835     EISSN: 20084625     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Van de Ven AA, Compeer EB, van Montfrans JM, Boes M. B-cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutations. Crit Rev Immunol 2011;31(2):85-98.
2. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92 (1):34-48.
3. Webster ADB. Clinical and immunological spectrum of common variable immunodeficiency (CVID). Iran J Allergy Asthma Immunol 2004;(3) 3:103-113.
4. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000;120(2):225-231.
5. Blancas-Galicia L, Ramírez-Vargas NG, Espinosa-Rosales F. Common variable immunodeficiency. A clinical approach. Rev Invest Clin 2010;62(6):577-582.
6. Primary Immunodeficiency Diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 1999;118(Supplement 1):1-28.
7. Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011;165(1):1-7.
8. Yel L. Selective IgA deficiency. J Clin Immunol 2010;30(1):10-16.
9. Kaveri SV, Maddur MS, Hegde P, Lacroix-Desmazes S, Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol 2011;164(Suppl 2): 2-5.
10. Borte S, Pan-Hammarström Q, Liu C, Sack U, Borte M, Wagner U, Graf D, Hammarström L. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood 2009;114(19):4089-4098.
11. Moise A, Nedelcu FD, Toader MA, Sora SM, Tica A, Ferastraoaru DE, Constantinescu I. Primary immunodeficiencies of the B lymphocyte. J Med Life 2010;3(1):60-63.
12. De Gast GC, Wilkins SR, Webster AD, Rickinson A, Platts-Mills TA. Functional immaturity of isolated B cells from patients with hypogammaglobulinaemia. Clin Exp Immunol 1980;42(3):535-544.
13. Hammarstrom L, Smith CIE. Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs H, Smith CI, Puck J (eds). Primary immunodeficiency diseases a molecular and genetic approach. Oxford: Oxford University Press;1999, 250-262.
14. Schaffer FM, Palermos J, Zhu ZB, Barger BO, Cooper MD, Volanakis JE. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci USA 1989; 86(20):8015-8019.
15. Olerup O, Smith CIE, Björkander J, Hammarström L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci USA 1992;89 (22):10653-10657.
16. Carvalho Neves Forte W, Ferreira De Carvalho Jr F, Damaceno N, Vidal Perez F, Gonzales Lopes C, Mastroti RA. Evolution of IgA deficiency to IgG subclass deficiency and common variable immunodeficiency. Allergol Immunopathol 2000; 28(1):18-20.
17. Español T, Catala M, Hernandez M, Caragol I, Bertran JM. Development of a common variable immunodeficiency in IgA deficient patients. Clin Immunol Immunopathol 1996;80(3Pt 1):333-335.
18. Ishizaka A, Nakanishi M, Yamada S, Sakiyama Y, Matsumoto S. Development of hypogammaglobulinaemia in a patient with common variable immunodeficiency. Eur J Pediatr 1989;149(3):175-176.
19. Koistinen J. Familial clustering of selective IgA deficiency. Vox Sang 1976;30(3):181-190.
20. Oen K, Petty RE, Schroeder ML. Immunoglobulin A deficiency: genetic studies. Tissue Antigens 1982;19(3):174-182.
21. Conley ME, Cooper MD. Immature IgA B cells in IgA deficient patients. N Engl J Med 1981;305(9): 495-497.
22. Cooper MD, Lawton AR, Bockman DE. Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation. Lancet 1971;2 (7728):791-794.
23. Eisenstein EM, Chua K, Strober W. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10. J Immunol 1994;152 (12):5957-5968.
24. Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 1994; 91(3):1099-1103.
25. De La Concha EG, Fernandez-Arquero M, Martinez A, Vidal F, Vigil P, Conejero L, et al. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin Exp Immunol 1999;116(3):516-520.
26. Olerup O, Smith CIE, Hammarström L. Different amino acids at position 57 of the HLA-DQβ chain associated with susceptibility and resistance to IgA deficiency. Nature 1990;347(6290):289-290.
27. Schroeder HW Jr, Zhu ZB, March RE, Campbell RD, Berney SM, Nedospasov SA, et al. Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3,-B8,-A1 haplotypes. Mol Med 1998;4(2):72-86.
28. Shokri F, Mageed RA, Maziak BR, Jefferis R. Expression of VHIII-associated cross-reactive idiotype on human B lymphocytes. Association with staphylococcal protein A binding and Staphylococcus aureus Cowan I stimulation. J Immunol 1991; 146(3):936-940.
29. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39(5):225-235.
30. Wollheim FA, Belfrage S, Coster C, Lindholm H. Primary "acquired" hypogammaglobulinemia; clinical and genetic aspects of nine cases. Acta Med Scand 1964;176:1-16.
31. Fiore M, Pera C, Delfino L, Scotese I, Ferrara GB, Pignata C. DNA typing of DQ and DR alleles in IgA-deficient subjects. Eur J Immunogenet 1995; 22(5):403-411.
32. Amanzadeh A, Shokrgozar M. A, Samadi-Bahrami Z, Aghamohammadi A, Shokri F. Frequency analysis of HLA antigens in Iranian patients with common variable immunodeficiency. Arch Iranian Med 2003;6(1):16-22.
33. Olerup O, Smith CI, Hammarstrom L. Is selective IgA deficiency associated with central HLA genes or alleles of the DR-DQ region? Immunol Today 1991;12(4):134-136.
34. MacHulla HK, Schönermarck U, Schaaf A, Müller LP, Kloss C, Krüger J, Kunze G, et al. HLA-A, B, Cw and DRB1, DRB3/4/5/, DQB1, DPB1 frequencies in German immunoglobulin A-deficient individuals. Scand J Immunol 2000;52(2):207-211.
35. De la Concha EG, Fernandez-Arquero M, Gual L, Vigil P, Martinez A, Urcelay E, et al. MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J Immunol 2002;169(8):4637-4643.
36. Mohammadi J, Pourpak Z, Jarefors S, Saghafi S, Zendehdel K, Pourfathollah AA, et al. Human leukocyte antigens (HLA) associated with selective IgA deficiency in Iran and Sweden. Iran J Allergy Asthma Immunol 2008;7(4):209-214.
37. Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, et al. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol 2010;30 (1):138-143.
38. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the 11th International Histocompatibility Workshop and Conference. Vol 1. Oxford: Oxford University Press;1992:1067-1074,1141-1149.
39. Cuccia-Belvedere M, Monafo V, Martinetti M, Plebani A, De Paoli F, Burgio GR. Recurrent extended HLA haplotypes in children with selective IgA deficiency. Tissue Antigens 1989;34(2):127-132.
40. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune diseases. Mol Med 2011;17(11-12)1383-1396.
41. Waldrep ML, Zhuang Y, Schroeder HW Jr. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8. BMC Med Genet 2009;10:100.
42. Ferreira RC, Pan-Hammarström Q, Graham RR, Gateva V, Fontán G, Lee AT, et al. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet 2010;42(9): 777-780.
43. Pozo ND, Medrano LM, Cénit MC, Fernández-Arquero M, Ferreira A, García-Rodríguez MC, et al. MSH5 is not a genetic predisposing factor for immunoglobulin A deficiency but marks the HLADRB1* 0102 subgroup carrying susceptibility. Hum Immunol 2010;71(9):861-864.
44. Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997;159(12):6236-6241.
45. Czyzewska-Buczyñska A, Majkowska-Skrobek G, Jankowski A. Association of HLA-*08:DRB1*03 with immunoglobulin A-deficiency. Indian J Pediatr 2007;74(11):1021-1024.
46. Avila-Cariño J, Lewin N, Yamamoto K, Tomita Y, Mellstedt H, Brodin B, et al. EBV infection of BCLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype. Int J Cancer 1994;58(5):678-685.